{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:16:45Z","timestamp":1791145005344,"version":"4.1.0"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"\u201cMinisterio de Economia y Competitividad\u201d","doi-asserted-by":"crossref","award":["SAF2012-31217"],"award-info":[{"award-number":["SAF2012-31217"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.virusres.2015.02.024","type":"journal-article","created":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T14:32:34Z","timestamp":1425220354000},"page":"128-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["The Pneumovirinae fusion (F) protein: A common target for vaccines and antivirals"],"prefix":"10.1016","volume":"209","author":[{"given":"Jos\u00e9 A.","family":"Melero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Mas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.virusres.2015.02.024_bib0005","doi-asserted-by":"crossref","first-page":"B209","DOI":"10.1016\/j.vaccine.2012.11.106","article-title":"Strategic priorities for respiratory syncytial virus (RSV) vaccine development","volume":"31","author":"Anderson","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2015.02.024_bib0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.antiviral.2003.07.004","article-title":"Substituted benzimidazoles with nanomolar activity against respiratory syncytial virus","volume":"60","author":"Andries","year":"2003","journal-title":"Antiviral Res."},{"issue":"Pt 9","key":"10.1016\/j.virusres.2015.02.024_bib0015","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1099\/0022-1317-73-9-2225","article-title":"Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus","volume":"73","author":"Arbiza","year":"1992","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2015.02.024_bib0020","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1128\/JVI.63.7.2941-2950.1989","article-title":"Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function","volume":"63","author":"Beeler","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2015.02.024_bib0025","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1006\/viro.2002.1497","article-title":"Effect of proteolytic processing at two distinct sites on shape and aggregation of an anchorless fusion protein of human respiratory syncytial virus and fate of the intervening segment","volume":"298","author":"Begona Ruiz-Arguello","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2015.02.024_bib0030","doi-asserted-by":"crossref","first-page":"12877","DOI":"10.1128\/JVI.78.23.12877-12887.2004","article-title":"Recombinant human Metapneumovirus lacking the small hydrophobic SH and\/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate","volume":"78","author":"Biacchesi","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2015.02.024_bib0035","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nm1164","article-title":"Inhibition of respiratory viruses by nasally administered siRNA","volume":"11","author":"Bitko","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.virusres.2015.02.024_bib0040","doi-asserted-by":"crossref","first-page":"8973","DOI":"10.1128\/JVI.71.12.8973-8982.1997","article-title":"Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse","volume":"71","author":"Bukreyev","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2015.02.024_bib0045","doi-asserted-by":"crossref","first-page":"12191","DOI":"10.1128\/JVI.01604-08","article-title":"The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes","volume":"82","author":"Bukreyev","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2015.02.024_bib0050","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1128\/AAC.00211-07","article-title":"RSV604, a novel inhibitor of respiratory syncytial virus replication","volume":"51","author":"Chapman","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2015.02.024_bib0055","doi-asserted-by":"crossref","first-page":"15046","DOI":"10.1073\/pnas.0406696101","article-title":"Targeting a binding pocket within the trimer-of-hairpins: small-molecule inhibition of viral fusion","volume":"101","author":"Cianci","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virusres.2015.02.024_bib0060","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1128\/AAC.48.2.413-422.2004","article-title":"Orally active fusion inhibitor of respiratory syncytial virus","volume":"48","author":"Cianci","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2015.02.024_bib0065","series-title":"Fields Virology","first-page":"1086","article-title":"Respiratory syncytial virus and metapneumovirus","author":"Collins","year":"2013"},{"key":"10.1016\/j.virusres.2015.02.024_bib0070","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.virusres.2011.09.020","article-title":"Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years","volume":"162","author":"Collins","year":"2011","journal-title":"Virus Res."},{"issue":"Pt 12","key":"10.1016\/j.virusres.2015.02.024_bib0075","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1099\/0022-1317-72-12-3095","article-title":"Post-translational processing and oligomerization of the fusion glycoprotein of human respiratory syncytial virus","volume":"72","author":"Collins","year":"1991","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2015.02.024_bib0080","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1128\/JVI.65.3.1634-1637.1991","article-title":"Respiratory syncytial virus (RSV) F, G. M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived","volume":"65","author":"Connors","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2015.02.024_bib0085","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nature12442","article-title":"Cross-neutralization of four paramyxoviruses by a human monoclonal antibody","volume":"501","author":"Corti","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2015.02.024_bib0090","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1073\/pnas.0801433106","article-title":"Integrin alphavbeta1 promotes infection by human metapneumovirus","volume":"106","author":"Cseke","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virusres.2015.02.024_bib0095","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1177\/135965350801300603","article-title":"Inhibition of human metapneumovirus replication by small interfering RNA","volume":"13","author":"Deffrasnes","year":"2008","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.virusres.2015.02.024_bib0100","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1128\/AAC.00793-07","article-title":"Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus","volume":"52","author":"Deffrasnes","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2015.02.024_bib0105","doi-asserted-by":"crossref","first-page":"8800","DOI":"10.1073\/pnas.0912186107","article-title":"A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus","volume":"107","author":"Devincenzo","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virusres.2015.02.024_bib0110","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1401184","article-title":"Oral GS-5806 activity in a respiratory syncytial virus challenge study","volume":"371","author":"DeVincenzo","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virusres.2015.02.024_bib0115","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1128\/AAC.49.6.2460-2466.2005","article-title":"Small molecules VP-14637 and JNJ-2408068 inhibit respiratory syncytial virus fusion by similar mechanisms","volume":"49","author":"Douglas","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2015.02.024_bib0120","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/infdis\/174.3.456","article-title":"Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults","volume":"174","author":"Dowell","year":"1996","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2015.02.024_bib0125","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa043951","article-title":"Respiratory syncytial virus infection in elderly and high-risk adults","volume":"352","author":"Falsey","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virusres.2015.02.024_bib0130","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1086\/517376","article-title":"Relationship of serum antibody to risk of respiratory syncytial virus infection in elderly adults","volume":"177","author":"Falsey","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2015.02.024_bib0135","doi-asserted-by":"crossref","first-page":"24671","DOI":"10.1074\/jbc.M111.332791","article-title":"The small hydrophobic protein of the human respiratory syncytial virus forms pentameric ion channels","volume":"287","author":"Gan","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virusres.2015.02.024_bib0140","first-page":"543","article-title":"Risk of primary infection and reinfection with respiratory syncytial virus","volume":"140","author":"Glezen","year":"1986","journal-title":"Am. J. Dis. Child"},{"key":"10.1016\/j.virusres.2015.02.024_bib0145","doi-asserted-by":"crossref","first-page":"9859","DOI":"10.1073\/pnas.151098198","article-title":"Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion","volume":"98","author":"Gonzalez-Reyes","year":"2001","journal-title":"Proc. Natl. Acad. Sci U.S.A."},{"key":"10.1016\/j.virusres.2015.02.024_bib0150","first-page":"391","article-title":"Challenges and opportunities for respiratory syncytial virus vaccines","volume":"372","author":"Graham","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.virusres.2015.02.024_bib0155","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1203\/00006450-199308000-00013","article-title":"Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum","volume":"34","author":"Graham","year":"1993","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.virusres.2015.02.024_bib0160","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJM199311183292102","article-title":"Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group","volume":"329","author":"Groothuis","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virusres.2015.02.024_bib0165","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM198607103150201","article-title":"Respiratory syncytial viral infection in children with compromised immune function","volume":"315","author":"Hall","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virusres.2015.02.024_bib0170","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/infdis\/163.4.693","article-title":"Immunity to and frequency of reinfection with respiratory syncytial virus","volume":"163","author":"Hall","year":"1991","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2015.02.024_bib0175","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1006\/viro.2000.0293","article-title":"Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection","volume":"271","author":"Hallak","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2015.02.024_bib0180","doi-asserted-by":"crossref","first-page":"10508","DOI":"10.1128\/JVI.74.22.10508-10513.2000","article-title":"Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection","volume":"74","author":"Hallak","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2015.02.024_bib0185","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1128\/AAC.21.1.125","article-title":"In vivo inhibition of respiratory syncytial virus by ribavirin","volume":"21","author":"Hruska","year":"1982","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2015.02.024_bib0190","doi-asserted-by":"crossref","first-page":"e17665","DOI":"10.1371\/journal.pone.0017665","article-title":"Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules","volume":"6","author":"Hultberg","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.virusres.2015.02.024_bib0195","first-page":"259","article-title":"Live-attenuated respiratory syncytial virus vaccines","volume":"372","author":"Karron","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.virusres.2015.02.024_bib0200","doi-asserted-by":"crossref","first-page":"e1003309","DOI":"10.1371\/journal.ppat.1003309","article-title":"Host cell entry of respiratory syncytial virus involves macropinocytosis followed by proteolytic activation of the f protein","volume":"9","author":"Krzyzaniak","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virusres.2015.02.024_bib0205","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nm.2071","article-title":"Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming","volume":"16","author":"Kwakkenbos","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.virusres.2015.02.024_bib0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.1993.1561","article-title":"Paramyxovirus fusion: a hypothesis for changes","volume":"197","author":"Lamb","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2015.02.024_bib0215","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1073\/pnas.93.5.2186","article-title":"Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion","volume":"93","author":"Lambert","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virusres.2015.02.024_bib0220","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s007050050288","article-title":"Identification of a conserved neutralization site in the first heptad repeat of the fusion protein of respiratory syncytial virus","volume":"143","author":"Langedijk","year":"1998","journal-title":"Arch. Virol."},{"issue":"Pt 9","key":"10.1016\/j.virusres.2015.02.024_bib0225","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1099\/0022-1317-68-9-2521","article-title":"Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus","volume":"68","author":"Levine","year":"1987","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2015.02.024_bib0230","doi-asserted-by":"crossref","first-page":"13435","DOI":"10.1128\/JVI.01469-07","article-title":"Intracellular processing, glycosylation, and cell surface expression of human metapneumovirus attachment glycoprotein","volume":"81","author":"Liu","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2015.02.024_bib0235","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.1128\/JVI.72.8.6922-6928.1998","article-title":"Antigenic structure of human respiratory syncytial virus fusion glycoprotein","volume":"72","author":"Lopez","year":"1998","journal-title":"J. Virol."},{"issue":"Pt 12","key":"10.1016\/j.virusres.2015.02.024_bib0240","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1099\/0022-1317-74-12-2559","article-title":"Binding of neutralizing monoclonal antibodies to regions of the fusion protein of respiratory syncytial virus expressed in Escherichia coli","volume":"74","author":"Lounsbach","year":"1993","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2015.02.024_bib0245","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.antiviral.2010.10.004","article-title":"Two novel fusion inhibitors of human respiratory syncytial virus","volume":"88","author":"Lundin","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virusres.2015.02.024_bib0250","doi-asserted-by":"crossref","first-page":"7970","DOI":"10.1128\/JVI.00447-10","article-title":"Neutralization of human respiratory syncytial virus infectivity by antibodies and low-molecular-weight compounds targeted against the fusion glycoprotein","volume":"84","author":"Magro","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2015.02.024_bib0255","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1073\/pnas.1115941109","article-title":"Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention","volume":"109","author":"Magro","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virusres.2015.02.024_bib0260","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1099\/0022-1317-81-11-2715","article-title":"Binding of human respiratory syncytial virus to cells: implication of sulfated cell surface proteoglycans","volume":"81","author":"Martinez","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2015.02.024_bib0265","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1243283","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume":"342","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.virusres.2015.02.024_bib0270","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1126\/science.1234914","article-title":"Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody","volume":"340","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.virusres.2015.02.024_bib0275","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00555-11","article-title":"Structure of the respiratory syncytial virus fusion glycoprotein in the post-fusion conformation reveals preservation of neutralizing epitopes","author":"McLellan","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2015.02.024_bib0280","first-page":"433","article-title":"Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants","volume":"2","author":"Mejias","year":"2008","journal-title":"Biologics"},{"key":"10.1016\/j.virusres.2015.02.024_bib0285","first-page":"59","article-title":"Influence of respiratory syncytial virus strain differences on pathogenesis and immunity","volume":"372","author":"Melero","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.virusres.2015.02.024_bib0290","doi-asserted-by":"crossref","first-page":"11410","DOI":"10.1128\/JVI.01688-08","article-title":"An alphavirus replicon-based human metapneumovirus vaccine is immunogenic and protective in mice and cotton rats","volume":"82","author":"Mok","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2015.02.024_bib0295","first-page":"285","article-title":"Subunit and virus-like particle vaccine approaches for respiratory syncytial virus","volume":"372","author":"Morrison","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.virusres.2015.02.024_bib0300","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0042-6822(03)00115-6","article-title":"Structural characterization of respiratory syncytial virus fusion inhibitor escape mutants: homology model of the F protein and a syncytium formation assay","volume":"311","author":"Morton","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2015.02.024_bib0305","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis","volume":"375","author":"Nair","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.virusres.2015.02.024_bib0310","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1128\/JVI.63.5.2019-2029.1989","article-title":"The 1A protein of respiratory syncytial virus is an integral membrane protein present as multiple, structurally distinct species","volume":"63","author":"Olmsted","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2015.02.024_bib0315","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1073\/pnas.83.19.7462","article-title":"Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity","volume":"83","author":"Olmsted","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virusres.2015.02.024_bib0320","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijid.2014.03.1394","article-title":"Human metapneumovirus: review of an important respiratory pathogen","volume":"25","author":"Panda","year":"2014","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.virusres.2015.02.024_bib0325","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1006\/viro.1997.8696","article-title":"Membrane permeability changes induced in Escherichia coli by the SH protein of human respiratory syncytial virus","volume":"235","author":"Perez","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2015.02.024_bib0330","doi-asserted-by":"crossref","first-page":"8996","DOI":"10.1073\/pnas.0409478102","article-title":"The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin","volume":"102","author":"Polack","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virusres.2015.02.024_bib0335","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1128\/JVI.55.3.517-520.1985","article-title":"Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats","volume":"55","author":"Prince","year":"1985","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2015.02.024_bib0340","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1128\/JVI.68.7.4538-4546.1994","article-title":"The membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein G are synthesized from alternative initiation codons","volume":"68","author":"Roberts","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2015.02.024_bib0345","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0022-3476(94)70139-3","article-title":"Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: a double-blind, multicenter, placebo-controlled trial","volume":"125","author":"Rodriguez","year":"1994","journal-title":"J. Pediatr."},{"key":"10.1016\/j.virusres.2015.02.024_bib0350","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1073\/pnas.0910108106","article-title":"Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion protein","volume":"107","author":"Roymans","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virusres.2015.02.024_bib0355","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/jmv.20349","article-title":"Comparison of affinity chromatography and adsorption to vaccinia virus recombinant infected cells for depletion of antibodies directed against respiratory syncytial virus glycoproteins present in a human immunoglobulin preparation","volume":"76","author":"Sastre","year":"2005","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virusres.2015.02.024_bib0360","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1093\/infdis\/jir622","article-title":"Nanobodies(R) specific for respiratory syncytial virus fusion protein protect against infection by inhibition of fusion","volume":"204","author":"Schepens","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2015.02.024_bib0365","article-title":"A broadly neutralizing human monoclonal antibody exhibits in vivo efficacy against both human metapneumovirus and respiratory syncytial","author":"Schuster","year":"2014","journal-title":"Virus J. Infect. Dis."},{"key":"10.1016\/j.virusres.2015.02.024_bib0370","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1542\/pir.34-12-558","article-title":"Human metapneumovirus","volume":"34","author":"Schuster","year":"2013","journal-title":"Pediatr. Rev."},{"key":"10.1016\/j.virusres.2015.02.024_bib0375","doi-asserted-by":"crossref","first-page":"8942","DOI":"10.1128\/JVI.00676-08","article-title":"Efficient multiplication of human metapneumovirus in Vero cells expressing the transmembrane serine protease TMPRSS2","volume":"82","author":"Shirogane","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2015.02.024_bib0380","doi-asserted-by":"crossref","first-page":"6927","DOI":"10.1128\/JVI.78.13.6927-6937.2004","article-title":"The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness","volume":"78","author":"Skiadopoulos","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2015.02.024_bib0385","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1084\/jem.187.11.1921","article-title":"Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia","volume":"187","author":"Sparer","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virusres.2015.02.024_bib0390","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1128\/JVI.61.12.3855-3861.1987","article-title":"Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus","volume":"61","author":"Stott","year":"1987","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2015.02.024_bib0395","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01225-14","article-title":"A monomeric uncleaved RSV F antigen retains pre-fusion-specific neutralizing epitopes","author":"Swanson","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2015.02.024_bib0400","doi-asserted-by":"crossref","first-page":"9619","DOI":"10.1073\/pnas.1106536108","article-title":"Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers","volume":"108","author":"Swanson","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virusres.2015.02.024_bib0405","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.vaccine.2004.10.009","article-title":"A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys","volume":"23","author":"Tang","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2015.02.024_bib0410","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/nm.2444","article-title":"Identification of nucleolin as a cellular receptor for human respiratory syncytial virus","volume":"17","author":"Tayyari","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.virusres.2015.02.024_bib0415","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1006\/viro.2001.1340","article-title":"Respiratory syncytial virus with the fusion protein as its only viral glycoprotein is less dependent on cellular glycosaminoglycans for attachment than complete virus","volume":"294","author":"Techaarpornkul","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2015.02.024_bib0420","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/viro.2001.1138","article-title":"Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo","volume":"289","author":"Teng","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2015.02.024_bib0425","doi-asserted-by":"crossref","first-page":"11767","DOI":"10.1128\/JVI.01208-08","article-title":"Role of cellular glycosaminoglycans and charged regions of viral G protein in human metapneumovirus infection","volume":"82","author":"Thammawat","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2015.02.024_bib0430","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1099\/vir.0.2008\/005199-0","article-title":"Identification of antibody neutralization epitopes on the fusion protein of human metapneumovirus","volume":"89","author":"Ulbrandt","year":"2008","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2015.02.024_bib0435","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nsmb.2250","article-title":"Structure of the human metapneumovirus fusion protein with neutralizing antibody identifies a pneumovirus antigenic site","volume":"19","author":"Wen","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.virusres.2015.02.024_bib0440","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1073\/pnas.82.12.4075","article-title":"Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein","volume":"82","author":"Wertz","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virusres.2015.02.024_bib0445","doi-asserted-by":"crossref","first-page":"E3441","DOI":"10.1073\/pnas.1405198111","article-title":"Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors","volume":"111","author":"Yan","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virusres.2015.02.024_bib0450","doi-asserted-by":"crossref","first-page":"9288","DOI":"10.1073\/pnas.0503989102","article-title":"Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein","volume":"102","author":"Yin","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virusres.2015.02.024_bib0455","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nature04322","article-title":"Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation","volume":"439","author":"Yin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2015.02.024_bib0460","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nm1174","article-title":"Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene","volume":"11","author":"Zhang","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.virusres.2015.02.024_bib0465","doi-asserted-by":"crossref","first-page":"31642","DOI":"10.1074\/jbc.M102633200","article-title":"Proteolytic activation of respiratory syncytial virus fusion protein. Cleavage at two furin consensus sequences","volume":"276","author":"Zimmer","year":"2001","journal-title":"J. Biol. Chem."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170215001148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170215001148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T02:58:51Z","timestamp":1651373931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170215001148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":93,"alternative-id":["S0168170215001148"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2015.02.024","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Pneumovirinae fusion (F) protein: A common target for vaccines and antivirals","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2015.02.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}